Aphranel, a Chinese regenerative medical aesthetics brand, recognized in Forbes China Beauty 100 for innovation and growth potential in beauty and medical aesthetics.
Aphranel selected for Forbes China Beauty Brands Top 100
Aphranel, a medical aesthetic brand under Moyoung Biotech, has been selected for Forbes China's Top 100 Beauty Brands, recognizing its innovation and brand development in the industry.
Aphranel launches global expert panel on regenerative aesthetics
Aphranel convened a conference in Thailand, launching the MagiC Concept Global Expert Advisory Panel to advance regenerative aesthetic medicine through anatomical research and international collaboration.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.